Women's Health Cluster Drug Development Pipeline Review, 2017 Published: May 2017 Single User PDF: US$ 3995 Order this report by calling or Send an to with your contact details and questions if 1 © ReportsnReports.com / Contact

Women's Health Cluster Drug Development Pipeline Review, 2017 Women's Health Cluster Pipeline Infertility Market Review in 2017 Report provides an overview of the women’s health pipeline landscape. The Women's Health Cluster Infertility Market Pipeline Overview in 2017 report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for female infertility, polycystic ovarian syndrome and endometriosis, and also features dormant and discontinued projects.Women's Health Cluster Infertility Market Pipeline Overview in 2017 report Infertility is defined as the inability to get pregnant after a year of unprotected intercourse. Female infertility can be also be caused by a number of factors, which include damage to fallopian tubes, hormonal causes, cervical causes, uterine causes, unexplained infertility. There are a total of 87 products in development for this indication, by 47 companies and 11 academic institutions. Access Complete Report at: cluster-drug-development-pipeline-review-2017.html. cluster-drug-development-pipeline-review-2017.html Offers from 10th May 2017 to 2nd June 2017 All reports priced >=1,000 – 20% Discount – Single User ; 25% Discount – Global Site License. Buy 2 Reports Get 1 Report Free Order this report by calling or Send an to with your contact details and questions if any. 2 © ReportsnReports.com / Contact

Women's Health Cluster Drug Development Pipeline Review, 2017 Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms include menstrual abnormality, acne, thinning hair on the scalp, weight gain, excess androgen and polycystic ovaries. There are a total of 12 products in development for this indication, by eight companies and three academic institutions. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (the endometrium) grows outside the uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. There are a total of 53 products in development for this indication, by 29 companies and eight academic institutions. Inquire for Discount Order this report by calling or Send an to with your contact details and questions if any. 3© ReportsnReports.com / Contact

Women's Health Cluster Drug Development Pipeline Review, 2017 The main types of therapy being developed act on hormone receptors, reflecting the hormone- driven pathophysiology of this disease area. However, particularly in polycystic ovarian syndrome, a broader range of molecular targets, such as intracellular protein kinases, chemokine receptors and other cell signaling components are also targeted. Key Companies Operating in this Pipeline include: Bayer Evotec AlphaMab Zydus Cadila Healthcare Ferring EffRx Buy a Copy of Order this report by calling or Send an to with your contact details and questions if any. 4© ReportsnReports.com / Contact

Women's Health Cluster Drug Development Pipeline Review, 2017 Scope of the Report Which companies are the most active within the pipeline for women’s health therapeutics? Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication? To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies? What are the most important R&D milestones and data publications to have happened in the field of women’s health therapeutics? Buy a Copy of Order this report by calling or Send an to with your contact details and questions if any. 5 © ReportsnReports.com / Contact

Women's Health Cluster Drug Development Pipeline Review, 2017 List of Figures Number of Products under Development for Women Infertility Number of Products under Development by Companies, Women Infertility Number of Products under Development by Universities/Institutes, Women Infertility Number of Products under Development for Polycystic Ovarian Syndrome Number of Products under Development by Companies, Polycystic Ovarian Syndrome Number of Products under Development for Endometriosis Number of Products under Development by Companies, Endometriosis Number of Products under Development by Universities/Institutes, Endometriosis Number of Products by Top 10 Targets, Women Infertility Sample for the Order this report by calling or Send an to with your contact details and questions if any. 6 © ReportsnReports.com / Contact

About ReportsnReports ReportsnReports.comReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Contact: Ritesh Tiwari Maharashtra, India. Tel: © ReportsnReports.com / Contact